Skip to main content
. Author manuscript; available in PMC: 2019 Jul 6.
Published in final edited form as: Org Lett. 2018 Jun 19;20(13):4020–4022. doi: 10.1021/acs.orglett.8b01578

Figure 3.

Figure 3.

HKE2 inhibits platelet aggregation. Human platelet-rich plasma was preincubated with vehicle (v) or HKE2 (1 μM) obtained from chemical synthesis (A) or enzymatic synthesis (B) for 10 min at 37 °C before stimulation of aggregation by the thromboxane receptor agonist U46,619.17